Literature DB >> 15231569

Human CD62L- memory T cells are less responsive to alloantigen stimulation than CD62L+ naive T cells: potential for adoptive immunotherapy and allodepletion.

Aaron E Foster1, Marina Marangolo, Mary M Sartor, Stephen I Alexander, Min Hu, Kenneth F Bradstock, David J Gottlieb.   

Abstract

Selective depletion of alloreactive T cells from allogeneic stem cell grafts can reduce graft-versus-host disease (GVHD) while preserving beneficial effects of T cells including facilitation of engraftment, protection against opportunistic infection, and reduced relapse risk. Memory T cells (CD62L(-)) represent a population of T cells that have previously encountered pathogens and may contain fewer T cells capable of recognizing neoantigens including recipient allogeneic antigen (aAg). We investigated whether human naive (CD62L(+)) or memory (CD62L(-)) T cells had different capacities to respond to aAg by assessing their ability to proliferate in response to and lyse HLA-mismatched Epstein-Barr virus-transformed B cells. Freshly sorted and in vitro expanded CD62L(-) memory T cells were less responsive to aAg stimulation than were CD62L(+) naive T cells but contained higher levels of cytomegalovirus (CMV)-specific T cells. Analysis of T cell receptor (TCR) repertoire showed restricted TCR diversity in the memory T-cell population possibly due to selection associated with chronic exposure to common pathogens. Memory T cells may represent a donor cell subpopulation suitable for enhancing immune reconstitution without increasing the risk of GVHD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15231569     DOI: 10.1182/blood-2003-12-4431

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.

Authors:  Wannee Asavaroengchai; Hui Wang; Shumei Wang; Lan Wang; Roderick Bronson; Megan Sykes; Yong-Guang Yang
Journal:  Biol Blood Marrow Transplant       Date:  2007-01       Impact factor: 5.742

2.  A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

Authors:  Hiroki Torikai; Andreas Reik; Pei-Qi Liu; Yuanyue Zhou; Ling Zhang; Sourindra Maiti; Helen Huls; Jeffrey C Miller; Partow Kebriaei; Brian Rabinovich; Brian Rabinovitch; Dean A Lee; Richard E Champlin; Chiara Bonini; Luigi Naldini; Edward J Rebar; Philip D Gregory; Michael C Holmes; Laurence J N Cooper
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

3.  Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.

Authors:  D Teschner; E Distler; D Wehler; M Frey; D Marandiuc; K Langeveld; M Theobald; S Thomas; W Herr
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

4.  High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.

Authors:  S-Y Lu; K-Y Liu; D-H Liu; L-P Xu; X-J Huang
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

5.  Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunity.

Authors:  B Choufi; J Trauet; S Thiant; M Labalette; I Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2014-02-24       Impact factor: 5.483

6.  Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads.

Authors:  S Verfuerth; P S E Sousa; L Beloki; M Murray; M D Peters; A T O'Neill; S Mackinnon; M W Lowdell; R Chakraverty; E R Samuel
Journal:  Bone Marrow Transplant       Date:  2015-06-15       Impact factor: 5.483

7.  Haploidentical HSCT: a 15-year experience at San Raffaele.

Authors:  C Bonini; J Peccatori; M T L Stanghellini; L Vago; A Bondanza; N Cieri; R Greco; M Bernardi; C Corti; G Oliveira; E Zappone; C Traversari; C Bordignon; F Ciceri
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

8.  Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion.

Authors:  Stephanie L Goff; Laura A Johnson; Mary A Black; Hui Xu; Zhili Zheng; Cyrille J Cohen; Richard A Morgan; Steven A Rosenberg; Steven A Feldman
Journal:  Cancer Immunol Immunother       Date:  2010-07-14       Impact factor: 6.968

9.  Cytolytic mechanisms and T-cell receptor Vbeta usage by ex vivo generated Epstein-Barr virus-specific cytotoxic T lymphocytes.

Authors:  Victoria J Vanhoutte; Karen A McAulay; Erin McCarrell; Marc Turner; Dorothy H Crawford; Tanzina Haque
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

10.  Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.

Authors:  Katie Matthews; ZiYi Lim; Behdad Afzali; Laurence Pearce; Atiyeh Abdallah; Shahram Kordasti; Antonio Pagliuca; Giovanna Lombardi; J Alejandro Madrigal; Ghulam J Mufti; Linda D Barber
Journal:  Haematologica       Date:  2009-06-02       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.